Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.15

-0.13

-0.1

-0.08

Details

Expected EPS

-0.108333

Actual EPS

-0.1

Surprise EPS

0.01

Surprise Percent

+7.69%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.1 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.